112 results on '"Ferraioli, M"'
Search Results
52. Corso di diritto processuale penale
- Author
-
Null, D and Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1992
53. Le misure cautelari
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1991
54. L'incidente probatorio
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1991
55. Ectopic Suprasellar Pituitary Adenoma
- Author
-
Caranci, F., primary, Cirillo, L., additional, Bartiromo, F., additional, Ferraioli, M., additional, Del Basso De Caro, M.L., additional, Esposito, F., additional, Cappabianca, P., additional, Brunetti, A., additional, and Elefante, R., additional
- Published
- 2006
- Full Text
- View/download PDF
56. Molecular mechanisms involved in GnRH analogue‐related apoptosis for uterine leiomyomas.
- Author
-
Bifulco, G., Miele, C., Pellicano, M., Trencia, A., Ferraioli, M., Paturzo, F., Tommaselli, G.A., Beguinot, F., and Nappi, C.
- Published
- 2004
- Full Text
- View/download PDF
57. Acquiescenza
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1988
58. Disorientamenti giurisprudenziali in tema di rapporti tra acquiescenza e denuncia di conflitto
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1983
59. Recensioni a G. Pansini, I giudizi direttissimi atipici, e ad A. Gaito, Il giudizio direttissimo
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1982
60. voce Segreto (§1-8)
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1986
61. Le misure di cautela personale
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1989
62. Diffamazione nell'adempimento delle funzioni giudiziarie?
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1980
63. Il riesame dei provvedimenti sulla libertà personale
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1988
64. Giudizio abbreviato
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1989
65. Presunzione
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1986
66. Il procedimento per l'irrogazione delle sanzioni disciplinari
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1977
67. Discrezionalità del giudice e imposizione di obblighi allo scarcerato
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1987
68. Sull'impugnabilità dell'ordine o mandato di cattura ineseguito per latitanza dell'imputato
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1977
69. Conflitti di competenza e rimessione di uno dei procedimenti connessi
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1978
70. Recensione agli atti del Convegno su 'Il giudice istruttore tra accusa e giurisdizione'
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1982
71. Osservazioni in tema di competenza territoriale per i reati valutari
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1981
72. Osservazione sul regime delle nullità dopo la l. 8 agosto 1977
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1980
73. Osservazioni in tema di conflitti di competenza e di giurisdizione
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1980
74. Appunti di procedura penale, per gli studenti del Corso di procedura penale, anno accademico 1988/89, Roma-Salerno
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1989
75. Il sistema disciplinare: ricompense e punizioni
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1981
76. I conflitti di competenza nel processo penale
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1984
77. Riflessioni sul diritto dell'imputato a non collaborare
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1982
78. Commento all'art. 80 l. 1/4/1981 n. 121
- Author
-
Ferraioli, M
- Subjects
Settore IUS/16 - Diritto Processuale Penale - Published
- 1982
79. Structural identification from environmental vibration testing of an asymmetric-plan hospital building in Italy
- Author
-
Ferraioli, M., Donato Abruzzese, Miccoli, L., Vari, A., Di Lauro, G., Ferraioli, Massimiliano, Abruzzese, D, Miccoli, L, Vari, A, and DI LAURO, G.
- Abstract
The structural identification from environmental vibration testing of a hospital building in Avezzano (Abruzzo - Italy) was presented. The comparison of the results enables to verify and calibrate numerical pre-dictions on the base of data obtained from modal testing. The response of the structure in the time domain was recorded by highly sensitive sensor network, integrated by a data acquisition system. The identification was performed using techniques of modal extraction in the frequency domain (frequency domain de-composition). During the calibration process of the numerical model the values initially adopted were successively corrected in order to identify a reliable structural model to be used to have an accurate seismic vulnerability assessment of the hospital building.
80. Progressive collapse of seismic resistant multistory frame buildings
- Author
-
Ferraioli, M., Alberto Maria Avossa, IALCCE, Alfred Strauss, Dan M. Frangopol and Konrad Bergmaister, Ferraioli, Massimiliano, and Avossa, Alberto Maria
- Subjects
Safety, Risk, Reliability and Quality ,Civil and Structural Engineering - Abstract
This paper evaluate the potential for progressive collapse of steel moment-resisting frame buildings designed according to the Italian Seismic Code. Three analysis procedures (linear static, nonlinear static and nonlinear dynamic) are applied to the problem of disproportionate collapse of steel moment frames due to a sudden column loss. In particular, a technique termed pushdown analysis that is inspired by the pushover method commonly used in earthquake engineering is applied to investigate the robustness of building for various missing column scenarios. The results are compared with dynamic analyses, and the dependence from location of column removal and number of building stories is finally investigated.
81. A design method for seismic retrofit of reinforced concrete frame buildings using aluminum shear panels
- Author
-
Massimiliano Ferraioli, Angelo Lavino, Gianfranco De Matteis, Ferraioli, M., Lavino, A., and De Matteis, G.
- Subjects
RC structure ,Seismic retrofit ,Mechanical Engineering ,Aluminum shear panel ,Design method ,Civil and Structural Engineering - Abstract
Despite significant progress in research and development of aluminum shear panels in recent decades, their implementation for seismic retrofit of existing reinforced concrete (RC) buildings can still be significantly extended. Their application is limited by the general lack of relatively simple and effective design criteria and proper guidelines. This paper develops a design method for the seismic retrofit of reinforced concrete buildings using aluminum multi-stiffened shear panels as dampers. Both the nonlinearity in the structure and the dampers-structure interaction are considered to give an optimal distribution of the shear panels over the height of the building. The analytical laws refer to dissipative aluminum shear panels recently tested and analyzed by the authors. The proposed procedure has been described in detail. Its applicability has been demonstrated by analyzing two typical RC buildings having drift capacity-to-demand ratios ranging from 0.505 to 0.624. The design value of the panel-to-frame stiffness ratio has been found to range from 0.594 to 1.432 as a function of the lateral stiffness of the existing building. The verification of the proposed procedure has been carried out by checking the validity of the design assumptions. The first one (i.e., the mode shapes remain the same before and after retrofit) has been checked using the modal assurance criterion that gives values ranging from 0.992 to 0.998. The second one (i.e., uniform yield drift distribution over the building height) has been checked by comparing the yield drifts with their average value giving a standard deviation ranging from about 11 to 15%. The effectiveness of the design method has been finally validated through nonlinear time-history analysis for different seismic accelerograms and hysteresis models. The results show that the seismic retrofit design procedure is effective in significantly reducing inter-story drift (maximum inter-story drift ratio demands ranging from 1.04 to 2.07%) thus satisfying the acceptance criteria of the building, and avoiding drift concentration and consequential weak story collapse.
- Published
- 2023
- Full Text
- View/download PDF
82. Retrofit of a RC Building Against Seismic and Progressive Collapse Using Steel Bracing and Cabling
- Author
-
Massimiliano Ferraioli, Angelo Lavino, Alberto Mandara, vari, Federico M. Mazzolani, Dan Dubina, Aurel Stratan, Ferraioli, M., Lavino, A., and Mandara, A.
- Subjects
Metal shear panel ,RC building ,Seismic retrofit ,Design method - Abstract
The retrofit of a RC hospital building using low impact strengthening techniques based on steel bracing and cabling is illustrated in the paper. A preliminary investigation of the seismic performance capability of the building has been made, in such a way to address the possibility to improve the earthquake protection together with structural robustness. Out of the possible low impact structural solutions, the ones relying on steel concentric braces and catenary cables have been considered and analyzed in detail. The proposed solutions are critically examined as to parameters like ease of implementation, global impact on the construction, and intervention reversibility. Both seismic and progressive collapse resisting capacity of the retrofitted building are assessed and discussed based on nonlinear static and dynamic analyses.
- Published
- 2022
83. Progressive Collapse Assessment and Retrofit of a Multistory Steel Braced Office Building
- Author
-
Massimiliano Ferraioli, Angelo Lavino, Alberto Mandara, Ferraioli, M., Lavino, A., and Mandara, A.
- Subjects
Seismic retrofit ,Nonlinear analysi ,Progressive collapse ,Steel braced frame ,Civil and Structural Engineering - Abstract
The progressive collapse of the building structures due to abnormal loads has attracted global attention in recent years. Many studies in the literature have been dedicated to the analysis and design procedures for progressive collapse resistance, and several technological solutions have been developed for progressive collapse retrofit. However, many studies are based on simple models and their validity and possibility to generalize the research results to current practice are rather limited. Moreover, there are still not many case studies developed based on full-scale real buildings. The present paper contributes to filling this gap by investigating the robustness of a quite complex real case study, namely a steel braced frame building erected in the early ‘60 s in Naples-Italy to house the Civil Engineering Authority. To this aim, different column removal scenarios have been considered and both nonlinear static and dynamic analyses have been carried out. The results have highlighted that the simple braced frames are susceptible to progressive collapse due to the weak brace connections. However, joint strengthening is not a viable solution, because it would prevent the full functionality of this strategic building during the implementation of the progressive collapse retrofit. As an alternative, an outrigger-belt truss system has been developed that applies the concept of Vierendeel truss system to redistribute the loads due to the column removal. The effectiveness of the proposed retrofit strategy to improve the progressive collapse resistance of the building has been verified through nonlinear dynamic analyses, proving its feasibility for practical applications.
- Published
- 2022
84. Progressive Collapse Retrofit of a RC Hospital Building Using Steel Braces
- Author
-
Massimiliano Ferraioli, Angelo Lavino, Alberto Mandara, M. Ferraioli, A. Lavino, A. Mandara, Ferraioli, M., Lavino, A., and Mandara, A.
- Subjects
RC building ,Steel bracing ,Progressive collapse ,Retrofit - Abstract
The progressive collapse retrofit of a RC hospital building making use of steel braces is described in the paper. The vulnerability of the construction when subjected to specific threat scenarios is preliminary analysed by removing critical column and applying the alternate load path method to evaluate the capability of the damaged structure to bridge across the removed column. A detailed three-dimensional model of the building has been created to carry out both nonlinear static and nonlinear dynamic analyses. Both geometrical and material nonlinearities have been considered in the analysis in order to account for the inelastic behaviour following the sudden column removal and the possible subsequent catenary effects. In order to retrofit the building against progressive collapse the use of steel braces in some bays has been proposed, designed on the basis on simple equilibrium conditions under vertical loads. The retrofitting bracing system proved to be effective in improving the global building behaviour under several accidental scenarios.
- Published
- 2022
85. Seismic performance of a reinforced concrete building retrofitted with self-centering shape memory alloy braces
- Author
-
Massimiliano Ferraioli, Antonio Concilio, Carmine Molitierno, Ferraioli, M., Concilio, A., Molitierno, C., M. Ferraioli, A. Concilio, C. Molitierno, G. Ferro, L. Restuccia, Ferraioli, Massimiliano, Concilio, Antonio, and Molitierno, Carmine
- Subjects
RC building ,self-centering ,Mechanical Engineering ,shape memory alloys dampers ,Building and Construction ,Geotechnical Engineering and Engineering Geology ,buckling-restrained brace ,RC buildings, Seismic retrofit, Buckling-restrained braces, Shape memory alloys dampers, Self-centering ,Civil and Structural Engineering ,Earth-Surface Processes ,seismic retrofit - Abstract
In recent years, a new generation of seismic lateral force resisting systems has been proposed that sustains little or no damage under severe earthquakes thus reducing the repair time and cost. This has stimulated the development of many types of self-centering (SC) earthquake-resistant systems even based on innovative materials. Among them, shape memory alloy (SMA) dampers have been proposed that use superelastic nitinol wires to dissipate energy and self-center the structure. Many studies have been dedicated to SMA-brace devices applied to steel moment frames. Only a few studies have employed these devices for the seismic retrofit of existing reinforced concrete buildings. Moreover, their applicability has been experimentally and numerically tested only on small scale brace-components, while applications to real RC buildings are still lacking. Finally, there is a general lack of reliable design procedures. This paper presents a study that investigates the seismic performance of a reinforced concrete building retrofitted with self-centering (SC) shape memory alloy (SMA) braces. A design procedure is applied that satisfies displacement-based performance criteria and allocates the damped braces over the height according to an optimal damper distribution rule. Finally, nonlinear response-history analyses are carried out to evaluate the effectiveness of both the self-centering retrofit solution and the design procedure. The results show the excellent recentering behavior of the SC-SMA braces together with their not negligible energy dissipation capacity.
- Published
- 2022
86. Seismic retrofit of an existing reinforced concrete building with buckling-restrained braces
- Author
-
Angelo Lavino, Carmine Molitierno, Gennaro Di Lauro, Massimiliano Ferraioli, Ferraioli, M., Lavino, A., Molitierno, C., and Di Lauro, G.
- Subjects
Reinforced concrete building ,Seismic retrofit ,business.industry ,Computer science ,020101 civil engineering ,02 engineering and technology ,Structural engineering ,Nonlinear time-history analysi ,021001 nanoscience & nanotechnology ,Reinforced concrete ,SDOF system ,0201 civil engineering ,Buckling ,Buckling-restrained brace ,0210 nano-technology ,business ,Hysteretic damper ,Civil and Structural Engineering - Abstract
Background: The seismic retrofitting of frame structures using hysteretic dampers is a very effective strategy to mitigate earthquake-induced risks. However, its application in current practice is rather limited since simple and efficient design methods are still lacking, and the more accurate time-history analysis is time-consuming and computationally demanding. Aims: This paper develops and applies a seismic retrofit design method to a complex real case study: An eight-story reinforced concrete residential building equipped with buckling-restrained braces. Methods: The design method permits the peak seismic response to be predicted, as well as the dampers to be added in the structure to obtain a uniform distribution of the ductility demand. For that purpose, a pushover analysis with the first mode load pattern is carried out. The corresponding story pushover curves are first idealized using a degrading trilinear model and then used to define the SDOF (Single Degree-of-Freedom) system equivalent to the RC frame. The SDOF system, equivalent to the damped braces, is designed to meet performance criteria based on a target drift angle. An optimal damper distribution rule is used to distribute the damped braces along the elevation to maximize the use of all dampers and obtain a uniform distribution of the ductility demand. Results: The effectiveness of the seismic retrofit is finally demonstrated by non-linear time-history analysis using a set of earthquake ground motions with various hazard levels. Conclusion: The results proved the design procedure is feasible and effective since it achieves the performance objectives of damage control in structural members and uniform ductility demand in dampers.
- Published
- 2021
87. Dynamic monitoring of an existing reinforced concrete building in naples port area
- Author
-
Gianfranco De Matteis, Corrado Chisari, Costantino Dell’Aversano, Adele Vasaturo, Pasquale Bencivenga, Vittorio Pasquino, Massimiliano Ferraioli, Bencivenga, P., Chisari, C., Dell'Aversano, C., Pasquino, V., Ferraioli, M., Vasaturo, A., and De Matteis, G.
- Subjects
021110 strategic, defence & security studies ,Dynamic monitoring ,0211 other engineering and technologies ,020101 civil engineering ,02 engineering and technology ,Accelerometer ,Reinforced concrete ,Structural assessment, Existing infrastructure heritage, Dynamic monitoring, Accelerometer, Dynamic response, Model updating ,Port (computer networking) ,Civil engineering ,Geology ,0201 civil engineering ,Civil and Structural Engineering - Abstract
Introduction: The conservation and preservation of existing buildings, in particular public infrastructures, is currently a significant issue in Italy and Europe, considering their strategic role and the risk represented by human losses, management issues and also economic disruption in case of collapse. In this context, the interest in conservation is not restricted to monumental or artistical buildings but also includes the several buildings composing the Italian infrastructural heritage, which in many cases are made of reinforced concrete and show signs of ageing after half a century and more from their construction. Methods: On the basis of these premises, in the present paper, a preliminary investigation on an infrastructural case study located in Naples port is presented. Such a study is part of a research activity aimed at defining critical structural issues of the central administrative building of the Central Tyrrhenian Sea Port System Authority. Results: A system of high-sensitivity and low-cost MEMS acceleration sensors were installed on the structure, with the aim of investigating its dynamic behaviour. A Finite Element model of the building was created, including information about material properties and cross-section details from prior experimental activities. A model updating procedure was carried out, based on the dynamic data collected by the monitoring system and post-processed to estimate the fundamental frequencies. Conclusion: This has allowed highlighting the main features of the dynamic response of the building, and the critical role played by deformability of infill panels and floors on the modal properties of the structure.
- Published
- 2021
88. Irregularity Effects of Masonry Infills on Nonlinear Seismic Behaviour of RC Buildings
- Author
-
Massimiliano Ferraioli, Angelo Lavino, Ferraioli, M., and Lavino, A.
- Subjects
Article Subject ,General Mathematics ,0211 other engineering and technologies ,020101 civil engineering ,02 engineering and technology ,0201 civil engineering ,medicine ,Infill ,QA1-939 ,021110 strategic, defence & security studies ,business.industry ,General Engineering ,Torsion (mechanics) ,Stiffness ,Structural engineering ,Masonry ,Engineering (General). Civil engineering (General) ,Infilled frames ,Cracking ,Nonlinear system ,Research studies ,medicine.symptom ,TA1-2040 ,business ,Geology ,Mathematics - Abstract
Despite extensive research studies, the seismic response of infilled reinforced concrete buildings remains an open problem due to both the complexity of the interaction between the infill and the frame and the large number of parameters involved. Thus, guidelines for both modelling and analysis are still lacking and the infill walls are normally treated as nonstructural components in seismic codes. However, it may be not conservative to neglect the influence of infills. In fact, the infill masonry walls may significantly affect the stiffness, strength, and energy dissipation capacity of RC buildings, even when they are regularly distributed. Recognizing this influence and its importance on the vulnerability of infilled frames, Eurocode 8 requires amplifying seismic action effects due to infills. In this paper, the effectiveness of the Eurocode 8 design provisions for infill irregularity in plan and/or elevation was investigated. To this aim, different in-plan layouts of infill walls were selected as marginal cases for which Eurocode 8 does not require amplification of the action effects due to the presence of infills, or the additional measures to counteract these effects are not mandatory. The seismic vulnerability of the infilled RC buildings was evaluated using nonlinear static and nonlinear dynamic analyses. Both cracking and crushing of masonry and stiffness and strength degradation were considered in the analysis. The effect of the layout of the masonry infills on the seismic response in terms of resistance and displacement was evaluated. Results show that in one of the case studies here examined, it is not conservative to neglect the influence of infill panels. In fact, structural failure due to torsion and soft-storey effects may occur even in cases where Eurocode 8 does not require the amplification of the action effects. Finally, the total shear demand on columns may be underestimated, even in cases where the code provisions for infills irregularity are not mandatory, and the additional shear demand in the columns induced by the masonry infill is very low.
- Published
- 2020
- Full Text
- View/download PDF
89. Ectopic Suprasellar Pituitary Adenoma
- Author
-
Luigi Cirillo, Raffaele Elefante, Arturo Brunetti, Ferdinando Caranci, M. Ferraioli, M.L. Del Basso De Caro, Felice Esposito, Paolo Cappabianca, F. Bartiromo, Caranci F, Cirillo L, Bartiromo F, Ferraioli M, Del Basso De Caro ML, Esposito F, Cappabianca P, Brunetti A, and Elefante R
- Subjects
medicine.medical_specialty ,endocrine system diseases ,Adenoma ,MAGNETIC RESONANCE IMAGING ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Pituitary adenoma ,medicine ,Radiology, Nuclear Medicine and imaging ,Diaphragma sellae ,medicine.diagnostic_test ,business.industry ,ectopic adenoma ,Magnetic resonance imaging ,General Medicine ,medicine.disease ,Surgery ,Transphenoidal approach ,sella turcica ,medicine.anatomical_structure ,Sella turcica ,Tuberculum sellae ,Neurology (clinical) ,Radiology ,business ,030217 neurology & neurosurgery - Abstract
The occurrence of a pituitary adenoma located entirely outside the sella turcica, so-called ectopic adenoma, is extremely rare. We report a case of a non secreting-pituitary adenoma located above the diaphragma sellae, with no invasion into the sella turcica, confirmed at surgery. The tumor was initially treated unsuccessfully by operations via the transphenoidal route. After initial negative exploration by the transphenoidal route, the patient was successfully treated by an endoscopic endonasal transphenoidal approach extended to the tuberculum sellae and the posterior planum sphenoidale to access the suprasellar supraglandular region. A brief review of ectopic adenomas and a discussion of the preoperative diagnosis are presented.
- Published
- 2006
- Full Text
- View/download PDF
90. Per la storia della pesca nel Mediterraneo
- Author
-
DE NICOLO', MARIA LUCIA, F.S. Abate. A. Abella, P. Accadia, P. Addis, F. Andaloro, G. Ambrosio, S. Angelini, G.D. Ardizzone, E. Arneri, A. Bartoli, G. Basilone, G. Bernardini, M. Berteletti, I. Biagiorri, F. Boero, C. Boglione, G. Bombace, A. Bonanno, G. Bono, P. Bronzi, G. Buonfiglio, B. Cammarata, A, Cannas, F. Capezzuto, F. Carbonari, A. Cardillo, R. Carlucci, P. Carpentieri, P. Carpi, E. Casola, M. Catania, S. Cataudella, A. Cau, L. Ceriola, E. Ciccotti, M. Coccia, F. Colloca, P. Conte, L. Conti, C. Costa, C. Costantini, M. Cozzolino, G. D'Onglia, A. De Felice, R. De Luca, M.l. De Nicolò, S. De Ranieri, M. Dell'Aquila, P. Di Dato, A. Di Natale, E. Felici, O,. Ferraioli, M. Ferretti, F. Fiorentino, E. Floris, S. Focardi, M.C. Folesa, A. Franco, M. Gambino, V. Gancitano, F. Garibaldi, G. Garofalo, S. Giangicomi, L. Giannini, M. Gilmozzi, O. Giovanardi, M. Gristina, E. Guendalini, E. Ianì, L. Lambanchi, L. Lanteri, M. Lariccia, G. Lembo, I. Leonori, M.S. Liberati, A. Ligas, I. Locci e altri, S. CATAUDELLA, M. SPAGNOLO, and M.L. De Nicolò
- Subjects
mari italiani ,RISORSE ITTICHE ,MEDITERRANEO ,PESCA ,TECNICHE PISCATORIE ,aquacoltura - Abstract
Lo studio sulle attività alieutiche nei secoli dell'età moderna consente di ricostruire una specifica storia del Mediterraneo che trova nel Cinquecento un'epoca di transizione tra antiche e nuove maniere di pescare. La ricerca sulle fonti archivistiche ha restituito un quadro assai efficace dell'evoluzione della pesca dal XVI al XIX secolo che permette di seguire il passaggio dalla pratiche piscatorie svolte prevalentemente in prossimità della costa, a tecniche di pesca a strascico in alto mare esercitate con l'ausilio di tipi navali e attrezzature fino a quel momento mai sperimentati. L'aumento della produzione sollecita anche una migliore organizzazione dello smercio del pesce con l'utilizzo di ghiaccio per bloccare il facile deperimento del prodotto (conserve, neviere) e favorirne il trasporto sulle lunghe distanze. Nonostante le non poche problematiche sociali e organizzative del settore si avvia la trasformazione del commercio ittico che porta fra Sette e Novecento, in virtù del significativo allargamento della rete distributiva del prodotto fresco, anche un radicale cambiamento nelle abitudini alimentari.
- Published
- 2012
91. Molecular mechanisms involved in GnRH analogue-related apoptosis for uterine leiomyomas
- Author
-
Giuseppe Bifulco, Carmine Nappi, F Beguinot, G A Tommaselli, Massimiliano Pellicano, Alessandra Trencia, M Ferraioli, C. Miele, Flora Paturzo, Bifulco, Giuseppe, Miele, C., Pellicano, M., Trencia, A., Ferraioli, M., Paturzo, F., Tommaselli, G. A., Beguinot, Francesco, and Nappi, Carmine
- Subjects
Agonist ,Embryology ,medicine.medical_specialty ,medicine.drug_class ,Apoptosis ,Gonadotropin-releasing hormone ,Biology ,Gonadotropin-Releasing Hormone ,Phosphatidylinositol 3-Kinases ,Internal medicine ,Genetics ,medicine ,Humans ,Molecular Biology ,PI3K/AKT/mTOR pathway ,Uterine leiomyoma ,Leiomyoma ,Kinase ,Obstetrics and Gynecology ,Cell Biology ,Endocrinology ,Reproductive Medicine ,Mitogen-activated protein kinase ,Uterine Neoplasms ,biology.protein ,Phosphorylation ,Leuprolide ,Developmental Biology - Abstract
GnRH agonist therapy is known to reduce uterine leiomyoma volume, although the molecular mechanisms responsible for this effect remain poorly understood. In this study, we have investigated the molecular mechanisms involved in the anti-proliferative effect of a GnRH agonist, leuprolide acetate (LA), in uterine leiomyomas obtained from six patients treated with LA for 3 months before surgery (group B), compared with tumours from six untreated patients (group A). To this end, we have evaluated the expression and the activity of molecules involved in the regulation of cell survival and proliferation. In group B, the total activity of PI3K was reduced by 60% compared with control samples. Furthermore, LA caused a reduction of PKB activation of approximately 50%, measured as serine 473 phosphorylation. In parallel with PKB reduction in LA samples, we observed a 60% reduction in the phosphorylation of its substrate BAD. While Bcl-xL/BAD association was not significantly modified in LA-treated leiomyomas, BAD/14.3.3 interaction was reduced, due to a 50% decreased 14.3.3 expression. In addition, LA was able to reduce the expression of the antiapoptotic proteins FLIP and PED/PEA15 by 70 and 50% respectively, compared with control samples. We next evaluated the activation of MAP kinases in leiomyomas. Activation of p42 and p44 MAP kinase isoforms was increased by 30% in group B. However, the phosphorylation of the transcription factor Elk1 was not increased in a similar fashion in LA-treated leiomyomas compared with group A. Thus, these data suggest that LA reduction of leiomyoma volume is mediated at least in part by a decreased activation of the PI3K/PKB survival pathway and by the suppression of antiapoptotic factors.
- Published
- 2004
92. The Effects of Smoking, Alcohol, and Dietary Habits on the Progression and Management of Spondyloarthritis.
- Author
-
Fatica M, Çela E, Ferraioli M, Costa L, Conigliaro P, Bergamini A, Caso F, and Chimenti MS
- Abstract
Spondyloarthritis (SpA) is a group of chronic inflammatory diseases affecting the spine and peripheral joints, causing pain, stiffness, and reduced mobility. This narrative review examines how lifestyle factors-specifically smoking, alcohol consumption, and unhealthy diet-contribute to the onset and progression of SpA. It highlights their impact on disease activity, comorbidities, radiographic damage, and treatment response. Therefore, healthcare providers are encouraged to support patients in making personalized lifestyle changes. These findings underscore the importance of a comprehensive approach to SpA management, integrating lifestyle modifications with conventional therapies for optimal disease control and improved outcomes.
- Published
- 2024
- Full Text
- View/download PDF
93. Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort.
- Author
-
Ramonda R, Lorenzin M, Chimenti MS, Atzeni F, Semeraro A, D'Angelo S, Selmi C, Ortolan A, Marchesoni A, Manara M, Luchetti Gentiloni MM, Santo L, Salvarani C, Cauli A, Rossini M, Amato G, Cozzi G, Scagnellato L, Ferraioli M, Carriero A, Fracassi E, Giorgio F, Doria A, Foti R, and Carletto A
- Subjects
- Humans, Male, Female, Middle Aged, Italy epidemiology, Treatment Outcome, Adult, Cohort Studies, Aged, Antirheumatic Agents therapeutic use, Antirheumatic Agents adverse effects, Follow-Up Studies, Prospective Studies, Antibodies, Monoclonal, Humanized therapeutic use, Antibodies, Monoclonal, Humanized adverse effects, Arthritis, Psoriatic drug therapy
- Abstract
Objectives: to evaluate over a 48-month follow-up period the: 1) long-term effectiveness and safety; 2) drug retention rate (DRR); 3) impact of comorbidities and bDMARDs line on MDA and DAPSA remission/low disease activity (LDA) of secukinumab in a multicenter Italian cohort of PsA patients., Methods: Consecutive PsA patients receiving secukinumab were followed prospectively in Italian centers between 2016 and 2023. Disease characteristics, previous/ongoing treatments, comorbidities and follow-up duration were recorded. Treatment response was evaluated at 6 and 12 months after initiation, and every year up to 48 months (T48). DRR was assessed according to clinical and demographic features, comorbidities and bDMARDs line. Adverse events (AE) were recorded., Results: Six hundred eighty-five patients [42.5% male] were enrolled; 32.9% naïve received secukinumab; 74.2% had ≥ 1 comorbidity. Overall, secukinumab yielded improved outcomes at T48: naïve maintained lower disease activity vs. non-naïve [DAPSA 4.0 (1.4-8.1) vs. 6.0 (2.2-10.4);p = 0.04]; 76.9% naïve and 66.2% non-naïve achieved MDA; MDA no comorbidities vs. 1-3 comorbidities 78.8% vs. 73.3% (p < 0.05), and MDA no comorbidities vs. > 3 comorbidities 78.8% vs. 48.7% (p < 0.001). DAPSA-REM and DAPSA-LDA rates were higher in naïve patients, albeit similar between those without comorbidities vs. 1-3 comorbidities, and slightly lower in those with > 3 comorbidities. Treatment was discontinued in 233 patients due to loss of effectiveness, and in 41 due to AE. The overall DRR at T48 was 66%, with differences according to bDMARDs line (p < 0.001), use of combined csDMARDs (p = 0.016), BMI (p = 0.037) and mono/oligoarthritis vs. polyarthritis (p = 0.012)., Conclusions: Secukinumab proved safe and effective, and patients achieved sustained remission with a notable drug retention rate at 4 years., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
94. The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in Psoriatic Arthritis.
- Author
-
Caso F, Fatica M, Ferraioli M, Megna M, Potestio L, Ruggiero A, Tommasino N, Maione F, Scarpa R, Chimenti MS, and Costa L
- Subjects
- Humans, Biological Products therapeutic use, Biological Products adverse effects, Inflammation immunology, Inflammation epidemiology, Inflammation drug therapy, Arthritis, Psoriatic drug therapy, Arthritis, Psoriatic epidemiology, Arthritis, Psoriatic immunology, Antirheumatic Agents therapeutic use, Antirheumatic Agents adverse effects, Comorbidity
- Abstract
Introduction: Psoriatic arthritis (PsA) is an immune-inflammatory disease that affects both joints and entheses, and with diverse extra-articular manifestations (psoriasis, inflammatory bowel disease (IBD), and uveitis). A wide range of comorbid conditions, including cardiovascular diseases, obesity, metabolic syndrome (MetS), nonalcoholic fatty liver disease (NAFLD), mental health disorders (depression/anxiety), and osteoporosis are highly prevalent in course of PsA.Biological DMARDs (bDMARD), including TNF-inhibitors (TNFi), Interleukin (IL-17i) and IL-23i represent the cornerstone of the management of active disease. The use of these therapies obviously requires considering comorbidities presence, safety aspects and contraindications., Areas Covered: The aim of this review is to describe the inflammatory mechanisms behind PsA comorbidities, and the role of bDMARDs in the prevention and treatment of these conditions in course of PsA., Expert Opinion: Tailoring therapeutic strategies to the individual characteristics of each PsA patient can be an effective approach to manage comorbidities, maximizing the efficacy of bDMARDs, and reducing the incidence of AEs. Identifying targets within disease pathways can guide research into therapeutics that address both PsA and comorbidities simultaneously, but more studies are advocated for clarifying the potential prevention and management of bDMARDs used for PsA.
- Published
- 2024
- Full Text
- View/download PDF
95. Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis.
- Author
-
Ramonda R, Lorenzin M, Chimenti MS, D'Angelo S, Marchesoni A, Selmi C, Lubrano E, Santo L, Luchetti Gentiloni MM, Atzeni F, Cauli A, Manara M, Rossini M, Foti R, Cozzi G, Scagnellato L, Ferraioli M, Carriero A, Luciano N, Ruzzon F, Fatica M, Fracassi E, Doria A, Foti R, and Carletto A
- Subjects
- Humans, Male, Female, Middle Aged, Italy, Adult, Treatment Outcome, Antirheumatic Agents therapeutic use, Antirheumatic Agents adverse effects, Prospective Studies, Cohort Studies, Antibodies, Monoclonal, Humanized therapeutic use, Antibodies, Monoclonal, Humanized adverse effects, Axial Spondyloarthritis drug therapy
- Abstract
Objectives: This study aims to evaluate in a real-life Italian multicenter cohort of axial spondyloarthritis (axSpA) (1) the 4-year effectiveness and safety of secukinumab, (2) the drug retention rate (DRR), and (3) the impact of the line of bDMARDs treatment, subtype of axSpA, and sex on achieving low disease activity (LDA) and very low disease activity (VLDA)., Methods: Consecutive axSpA patients receiving secukinumab between 2016 and 2023 were prospectively evaluated. Data on disease characteristics, previous/ongoing treatments, comorbidities, and follow-up duration were collected. Treatment response was evaluated at 6 and 12 months after initiation and yearly up to 48 months (T48). DRR and effectiveness outcomes were evaluated according to bDMARDs treatment, axSpA subtype, and sex. Infections and adverse events (AEs) were recorded., Results: We enrolled 272 patients (48.2% male; median age, 51; 39.7% HLA-B27+; 40.4% nr-axSpA), of whom 30.9% were naïve to secukinumab. Overall, secukinumab yielded improvement in effectiveness outcomes; the naïve patients maintained lower disease activity vs. the non-naïve ones. At T48, the LDA and VLDA rates were higher in naïve patients and in male individuals. Treatment was discontinued in 104 patients due to primary/secondary loss of effectiveness and in 34 patients due to AEs. The DRR at T48 was 67.4% in the whole population, regardless of treatment line, axSpA subtype, and sex., Conclusions: Secukinumab was safe and effective in all axSpA patients irrespective of treatment line, disease subtype, and sex. The patients achieved sustained 4-year remission and DRR., Competing Interests: RR has received honoraria and speaker fees from Novartis, Abbvie, Pfizer, MSD, and Janssen. CS has received consulting/speaker fees from AbbVie, Amgen, Alfa-Sigma, Biogen, Eli-Lilly, EUSA Pharma - Recordati, Galapagos, Janssen, Novartis, Octapharma, Pfizer, Recordati Rare Disease, SOBI and research support from AbbVie, Amgen, Janssen, Novartis, Pfizer. AM has received honoraria and speaker fees from Abbvie, Pfizer, MSD, UCB, Novartis, Janssen, and Eli-Lilly. LeS has received speaker fees from Jansen, Novartis, Pfizer, UCB, MSD, and Sanofi. AD has received honoraria and speaker fees from Novartis, AbbVie, Pfizer, MSD, Janssen.AC has received speaker fees from Novartis, Abbvie, Eli-Lilly and Janssen. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Ramonda, Lorenzin, Chimenti, D’Angelo, Marchesoni, Selmi, Lubrano, Santo, Luchetti Gentiloni, Atzeni, Cauli, Manara, Rossini, Foti, Cozzi, Scagnellato, Ferraioli, Carriero, Luciano, Ruzzon, Fatica, Fracassi, Doria, Foti and Carletto.)
- Published
- 2024
- Full Text
- View/download PDF
96. Risankizumab Efficacy in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Remission: A Case Report on Rheumatologic and Dermatologic Disease Manifestations with Literature Review.
- Author
-
Ferraioli M, Fiannacca L, Greco E, Cela E, Fatica M, Bergamini A, and Chimenti MS
- Abstract
SAPHO syndrome is a complex disease that encompasses both inflammatory arthritis and/or osteitis and dermatologic manifestations. It is considered a rare disease, in fact, no clinical trials have been conducted on its therapy and management. Therefore, therapeutic approach is based on small case studies. Here, we described the case of a 63-year-old woman affected by SAPHO syndrome, treated with the selective IL-23p19 antagonist, Risankizumab, after unsuccessful therapies with Methotrexate, Infliximab, Adalimumab, and an allergic reaction to Secukinumab. At the beginning of therapy, in November 2022, the patient presented with arthritis in both knees associated with palmar pustulosis and guttate psoriasis on the trunk. DAPSA score was 24, PtGA 80 mm, PASI score 11.1, and BSA 40%. Thereafter, Risankizumab was started at the standard dosage of 150 mg. At week 24 patient achieved clinical remission, DAPSA score was 8, PtGA was 30 mm, PASI was 1, and BSA 2.5. Patient maintained clinical remission state at the subsequent week 52 evaluation. At the same time, the patient did not report any adverse effects. Health-related quality of life was also assessed at the same time points aforementioned, showing significant improvement. In conclusion, this case report wants to point out the efficacy and safety of Risankizumab in SAPHO syndrome, reporting a sustained disease remission through a 12 months long follow-up period. We can consider IL-23p19 targeted therapy as a novel treatment option for SAPHO-with a high efficacy potential-especially on patients that have already been treated with other biologics., Competing Interests: The authors declare that they have no conflicts of interest., (Copyright © 2024 Mario Ferraioli et al.)
- Published
- 2024
- Full Text
- View/download PDF
97. Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts.
- Author
-
Perrotta FM, Scriffignano S, Triggianese P, Ferraioli M, Chimenti MS, and Lubrano E
- Subjects
- Humans, Male, Female, Middle Aged, Cross-Sectional Studies, Remission Induction, Severity of Illness Index, Arthritis, Psoriatic diagnosis, Arthritis, Psoriatic drug therapy, Physicians
- Abstract
Objective: The aim was to evaluate the sex differences in sensitivity, specificity, positive and negative predictive values, and likelihood ratio of the outcome indices minimal disease activity (MDA), Disease Activity Score for Psoriatic Arthritis (DAPSA), and Psoriatic Arthritis Impact of Disease (PsAID) with respect to clinical remission, evaluated from both the physician and patient perspective, in a multicenter cohort of patients with PsA., Methods: In this cross-sectional analysis of 2 longitudinal cohorts, all patients with PsA consecutively attending our rheumatology units were considered potentially eligible for the study. In all patients, a complete clinical examination was carried out. The DAPSA was calculated for each patient (DAPSA values ≤ 4 were considered as remission) and MDA was also evaluated. Patient and physician global assessment values ≤ 1 were considered as a surrogate of remission from the patient and physician perspective, respectively., Results: Two hundred seventy-two patients with PsA were enrolled (mean age 55.7 [SD 12.4]; 141 male, 131 female). In both sexes, MDA had good sensitivity and specificity toward remission as assessed by the rheumatologist. Remission according to DAPSA had excellent values of specificity but lacks sensitivity in both sexes. PsAID ≤ 4 had excellent values of sensitivity but lacked specificity in both sexes. Remission defined by DAPSA values was found to be more sensitive and specific in female patients (45.4% and 100%, respectively) than in male patients (33.3% and 84.2%, respectively) with respect to physician-judged remission., Conclusion: The results of this study demonstrate for the first time, to our knowledge, that some differences between the 2 sexes on the different outcome indices are possible. This could be important in the clinical management of patients with PsA., (Copyright © 2024 by the Journal of Rheumatology.)
- Published
- 2024
- Full Text
- View/download PDF
98. Clinical and imaging findings in enteropathic spondyloarthritis with special emphasize in diagnostic delay: a cross-sectional study.
- Author
-
Conigliaro P, D'Antonio A, Wlderk A, Sabuzi F, Ferraioli M, Sichi L, Da Ros V, Biancone L, Bergamini A, and Sole Chimenti M
- Abstract
Background: Enteropathic spondyloarthritides (eSpAs) are chronic inflammatory joint diseases associated with inflammatory bowel disease (IBD). Limited data are available on the prevalence since arthritis in IBD patients may be underestimated because medications may hide disease activity with a possible diagnostic delay., Objectives: We aimed to evaluate diagnostic delay in eSpA and explore associated demographic, clinical, and radiographic characteristics., Design: Single-centre cross-sectional study conducted on consecutive out-patients referred to the combined Gi-Rhe clinic (November 2018-October 2019)., Methods: We analysed eSpA patients for diagnostic delay, disease activity, inflammatory markers, conventional radiography (CR) and magnetic resonance images (MRI) of sacroiliac joints/spine., Results: A total of 190 eSpA patients [118 peripheral SpA, 72 axial (Ax) SpA including 44 non-radiographic (nr)-axSpA] were enrolled. axSpA patients had a higher prevalence of men sex, HLA-B27 positivity, uveitis and pancolitis compared with peripheral eSpA. Median diagnostic delay in eSpA was 48 months (IQR 6-77) with no difference between axial and peripheral patients. Radiographic-axial SpA (r-axSpA) patients displayed a higher diagnostic delay compared with nr-axSpA (median/IQR 36/17-129 versus 31/10-57 months, p = 0.03) and were older, with longer disease duration, low education status and high rate of employment than patients with nr-axSpA. r-axSpA patients with sclerosis, syndesmophytes and bridge at CR had higher diagnostic delay than those without lesions. Men showed higher prevalence of spine damage lesions than women as sclerosis, squaring, syndesmophytes and bridges. Longer disease duration was detected in patients with radiographic damage as bridge and sacroiliitis grade 3. On MRI, sacroiliac bone oedema was associated with reduced diagnostic delay, whereas bone erosions were associated with higher diagnostic delay compared with that in patients without these lesions. Patients with psoriasis displayed a higher diagnostic delay compared to those without skin involvement., Conclusion: Diagnostic delay was higher in r-axSpA compared with nr-axSpA despite the same treatment. Demographic, clinical features and radiological lesions were associated with diagnostic delay., Competing Interests: The authors declare that there is no conflict of interest., (© The Author(s), 2024.)
- Published
- 2024
- Full Text
- View/download PDF
99. Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis.
- Author
-
Scriffignano S, Perrotta FM, Conigliaro P, Ferraioli M, Triggianese P, Chimenti MS, and Lubrano E
- Abstract
Introduction: The aim of this work is to characterize which Minimal Disease Activity (MDA) domains are mainly achieved, based on different treatments, in psoriatic arthritis (PsA) patients. Moreover, the association between MDA achievement and the different treatment groups was assessed., Methods: We conducted a cross-sectional analysis of two longitudinal PsA groups. Inclusion criteria were: age ≥ 18 years, PsA diagnosis, stable treatment for at least 6 months. Patients were grouped depending on the therapy: group 1: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)/cyclooxygenase 2 inhibitors (COX2i)/steroids, group 2: conventional synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs), group 3: Tumor Necrosis Factor α inhibitors (TNFi), group 4: interleukin inhibitors (IL)12-23i or IL-23i, group 5: IL-17i, group 6: phosphodiesterase 4 inhibitors (PD4i). For each group, the achieved domains based on therapy were assessed. Multivariate logistic regression analysis was performed to assess the association between the treatment groups and the MDA achievement., Results: A total of 220 patients were enrolled, and MDA was achieved in 45.8% of them. In all treatment groups, the first MDA domains achieved were: body surface area ≤ 3, swollen joint count ≤ 1 and Leeds Enthesitis Index ≤ 1, while MDA domains less frequently achieved were Patient Global Assessment (PtgA) ≤ 2 cm and pain on visual analogue scale ≤ 1.5 cm. The logistic regression analysis showed higher odds ratios for the achievement of the MDA in those patients in groups 3 and 4., Conclusions: In each treatment group, MDA domains less frequently achieved were PtGA and pain, suggesting that "patient-driven domains" are still an unmet need. Due to the study design and the low number of patients in some groups, it is not possible to clearly define which MDA domain was achieved or not based on treatment; however, it seems that some differences could be present. If larger and prospective studies confirm our preliminary results, we could move toward a personalized/domain treatment approach in PsA., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
100. Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine.
- Author
-
Picchianti-Diamanti A, Navarra A, Aiello A, Laganà B, Cuzzi G, Salmi A, Vanini V, Maggi F, Meschi S, Matusali G, Notari S, Agrati C, Salemi S, Di Rosa R, Passarini D, Di Gioia V, Sesti G, Conti F, Spinelli FR, Corpolongo A, Chimenti MS, Ferraioli M, Sebastiani GD, Benucci M, Li Gobbi F, Santoro AP, Capri A, Puro V, Nicastri E, and Goletti D
- Abstract
Objectives : We aimed to analyse the incidence and severity of breakthrough infections (BIs) in rheumatoid arthritis (RA) patients after a COronaVIrus Disease 2019 (COVID-19) vaccination booster dose. Methods : We enrolled 194 RA patients and 1002 healthcare workers (HCWs) as controls. Clinical, lifestyle and demographic factors were collected at the time of the third dose, and immunogenicity analyses were carried out in a subgroup of patients at 4-6 weeks after the third dose. Results: BIs were experienced by 42% patients (82/194) with a median time since the last vaccination of 176 days. Older age (>50 years; aHR 0.38, 95% CI: 0.20-0.74), receiving conventional synthetic disease modifying antirheumatic drugs (csDMARDs) (aHR 0.52, 95%CI: 0.30-0.90) and having a titre of neutralising antibodies >20 (aHR 0.36, 95% CI: 0.12-1.07) were identified as protective factors. Conversely, anti-IL6R treatment and anti-CD20 therapy increased BI probability. BIs were mostly pauci-symptomatic, but the hospitalisation incidence was significantly higher than in HCWs (8.5% vs. 0.19%); the main risk factor was anti-CD20 therapy. Conclusions: Being older than 50 years and receiving csDMARDs were shown to be protective factors for BI, whereas anti-IL6R or anti-CD20 therapy increased the risk. Higher neutralising antibody titres were associated with a lower probability of BI. If confirmed in a larger population, the identification of a protective cut-off would allow a personalised risk-benefit therapeutic management of RA patients.
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.